Ajanta Pharma Limited (NSE:AJANTPHARM)
2,797.60
+16.30 (0.59%)
Apr 21, 2026, 3:30 PM IST
Ajanta Pharma Revenue
Ajanta Pharma had revenue of 13.75B INR in the quarter ending December 31, 2025, with 19.95% growth. This brings the company's revenue in the last twelve months to 52.02B, up 14.78% year-over-year. In the fiscal year ending March 31, 2025, Ajanta Pharma had annual revenue of 46.48B with 10.44% growth.
Revenue (ttm)
52.02B
Revenue Growth
+14.78%
P/S Ratio
6.68
Revenue / Employee
5.40M
Employees
9,628
Market Cap
347.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 46.48B | 4.39B | 10.44% |
| Mar 31, 2024 | 42.09B | 4.66B | 12.45% |
| Mar 31, 2023 | 37.43B | 4.02B | 12.02% |
| Mar 31, 2022 | 33.41B | 4.51B | 15.62% |
| Mar 31, 2021 | 28.90B | 3.02B | 11.66% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Ipca Laboratories | 95.06B |
| Piramal Pharma | 88.71B |
| Emcure Pharmaceuticals | 88.50B |
| Alembic Pharmaceuticals | 72.67B |
| Laurus Labs | 67.22B |
| Gland Pharma | 61.13B |
Ajanta Pharma News
- 7 hours ago - Pharma sector stocks today, April 21: Wockhardt surge 2.08%, Natco Pharma down 1.86%, Ajanta Pharma up 1.10% - Business Upturn
- 5 days ago - Pharma sector stocks today, April 16: Ajanta Pharma down 1.53%, Glenmark Pharma falls 1.23%, Lupin drops 1.08% - Business Upturn
- 8 days ago - Pharma sector stocks fall today, April 13: Biocon falls 2.35%, Cipla down 1.66%, Ajanta Pharma gains 0.77% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98% - Business Upturn
- 5 weeks ago - Pharma sector stocks today, March 17: Emcure Pharma surge 2.42%, Ajanta Pharma up 2.14%, Strides Pharma down 2.22% - Business Upturn
- 5 weeks ago - Pharma sector stocks today, March 13: Laurus Labs down 2.56%, Ajanta Pharma falls 1.88%, Granules India drops 2.14% - Business Upturn
- 7 weeks ago - Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26% - Business Upturn
- 2 months ago - Ajanta Pharma Ltd (BOM:532331) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus